UniProt ID | PLXB1_HUMAN | |
---|---|---|
UniProt AC | O43157 | |
Protein Name | Plexin-B1 | |
Gene Name | PLXNB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 2135 | |
Subcellular Localization |
Isoform 1: Cell membrane Single-pass type I membrane protein. Isoform 2: Secreted. Isoform 3: Secreted. |
|
Protein Description | Receptor for SEMA4D. Plays a role in RHOA activation and subsequent changes of the actin cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration.. | |
Protein Sequence | MPALGPALLQALWAGWVLTLQPLPPTAFTPNGTYLQHLARDPTSGTLYLGATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQLLLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAVSTVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSYEETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSRVCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSAAPPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDGTEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEWPGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQGSAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCGWCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQVAAMSPANISREETREVFLSVPDLPPLWPGESYSCHFGEHQSPALLTGSGVMCPSPDPSEAPVLPRGADYVSVSVELRFGAVVIAKTSLSFYDCVAVTELRPSAQCQACVSSRWGCNWCVWQHLCTHKASCDAGPMVASHQSPLVSPDPPARGGPSPSPPTAPKALATPAPDTLPVEPGAPSTATASDISPGASPSLLSPWGPWAGSGSISSPGSTGSPLHEEPSPPSPQNGPGTAVPAPTDFRPSATPEDLLASPLSPSEVAAVPPADPGPEALHPTVPLDLPPATVPATTFPGAMGSVKPALDWLTREGGELPEADEWTGGDAPAFSTSTLLSGDGDSAELEGPPAPLILPSSLDYQYDTPGLWELEEATLGASSCPCVESVQGSTLMPVHVEREIRLLGRNLHLFQDGPGDNECVMELEGLEVVVEARVECEPPPDTQCHVTCQQHQLSYEALQPELRVGLFLRRAGRLRVDSAEGLHVVLYDCSVGHGDCSRCQTAMPQYGCVWCEGERPRCVTREACGEAEAVATQCPAPLIHSVEPLTGPVDGGTRVTIRGSNLGQHVQDVLGMVTVAGVPCAVDAQEYEVSSSLVCITGASGEEVAGATAVEVPGRGRGVSEHDFAYQDPKVHSIFPARGPRAGGTRLTLNGSKLLTGRLEDIRVVVGDQPCHLLPEQQSEQLRCETSPRPTPATLPVAVWFGATERRLQRGQFKYTLDPNITSAGPTKSFLSGGREICVRGQNLDVVQTPRIRVTVVSRMLQPSQGLGRRRRVVPETACSLGPSCSSQQFEEPCHVNSSQLITCRTPALPGLPEDPWVRVEFILDNLVFDFATLNPTPFSYEADPTLQPLNPEDPTMPFRHKPGSVFSVEGENLDLAMSKEEVVAMIGDGPCVVKTLTRHHLYCEPPVEQPLPRHHALREAPDSLPEFTVQMGNLRFSLGHVQYDGESPGAFPVAAQVGLGVGTSLLALGVIIIVLMYRRKSKQALRDYKKVQIQLENLESSVRDRCKKEFTDLMTEMTDLTSDLLGSGIPFLDYKVYAERIFFPGHRESPLHRDLGVPESRRPTVEQGLGQLSNLLNSKLFLTKFIHTLESQRTFSARDRAYVASLLTVALHGKLEYFTDILRTLLSDLVAQYVAKNPKLMLRRTETVVEKLLTNWMSICLYTFVRDSVGEPLYMLFRGIKHQVDKGPVDSVTGKAKYTLNDNRLLREDVEYRPLTLNALLAVGPGAGEAQGVPVKVLDCDTISQAKEKMLDQLYKGVPLTQRPDPRTLDVEWRSGVAGHLILSDEDVTSEVQGLWRRLNTLQHYKVPDGATVALVPCLTKHVLRENQDYVPGERTPMLEDVDEGGIRPWHLVKPSDEPEPPRPRRGSLRGGERERAKAIPEIYLTRLLSMKGTLQKFVDDLFQVILSTSRPVPLAVKYFFDLLDEQAQQHGISDQDTIHIWKTNSLPLRFWINIIKNPQFVFDVQTSDNMDAVLLVIAQTFMDACTLADHKLGRDSPINKLLYARDIPRYKRMVERYYADIRQTVPASDQEMNSVLAELSWNYSGDLGARVALHELYKYINKYYDQIITALEEDGTAQKMQLGYRLQQIAAAVENKVTDL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
19 | Phosphorylation | LWAGWVLTLQPLPPT HHHCCEEECCCCCCC | 17.46 | 24043423 | |
26 | Phosphorylation | TLQPLPPTAFTPNGT ECCCCCCCCCCCCCC | 32.25 | 24043423 | |
29 | Phosphorylation | PLPPTAFTPNGTYLQ CCCCCCCCCCCCEEH | 17.24 | 24043423 | |
31 | N-linked_Glycosylation | PPTAFTPNGTYLQHL CCCCCCCCCCEEHHH | 53.00 | UniProtKB CARBOHYD | |
33 | Phosphorylation | TAFTPNGTYLQHLAR CCCCCCCCEEHHHHC | 27.91 | 24043423 | |
34 | Phosphorylation | AFTPNGTYLQHLARD CCCCCCCEEHHHHCC | 13.03 | 24043423 | |
227 | Phosphorylation | SAFARGASAYFLFLR HHHHHHHHHHHHHHH | 26.73 | 30257219 | |
229 | Phosphorylation | FARGASAYFLFLRRD HHHHHHHHHHHHHHH | 9.79 | 30257219 | |
241 | Phosphorylation | RRDLQAQSRAFRAYV HHHHHHHHHHHHHHH | 28.70 | 30257219 | |
334 | N-linked_Glycosylation | DEVDRLANRTRDACY HHHHHHHHHCCCCCC | 50.91 | UniProtKB CARBOHYD | |
543 | N-linked_Glycosylation | VAAMSPANISREETR HHHCCCCCCCHHHHH | 35.83 | UniProtKB CARBOHYD | |
674 | Phosphorylation | DAGPMVASHQSPLVS CCCCCCCCCCCCCCC | 15.62 | 21712546 | |
677 | Phosphorylation | PMVASHQSPLVSPDP CCCCCCCCCCCCCCC | 18.12 | 21712546 | |
691 | O-linked_Glycosylation | PPARGGPSPSPPTAP CCCCCCCCCCCCCCC | 41.08 | 63768519 | |
691 | Phosphorylation | PPARGGPSPSPPTAP CCCCCCCCCCCCCCC | 41.08 | 21712546 | |
693 | O-linked_Glycosylation | ARGGPSPSPPTAPKA CCCCCCCCCCCCCCC | 48.09 | 55832677 | |
693 | Phosphorylation | ARGGPSPSPPTAPKA CCCCCCCCCCCCCCC | 48.09 | 23403867 | |
696 | O-linked_Glycosylation | GPSPSPPTAPKALAT CCCCCCCCCCCCCCC | 60.00 | 55832681 | |
696 | Phosphorylation | GPSPSPPTAPKALAT CCCCCCCCCCCCCCC | 60.00 | - | |
790 | O-linked_Glycosylation | TPEDLLASPLSPSEV CHHHHHCCCCCHHHH | 26.75 | OGP | |
795 | O-linked_Glycosylation | LASPLSPSEVAAVPP HCCCCCHHHHCCCCC | 41.13 | OGP | |
834 | O-linked_Glycosylation | TFPGAMGSVKPALDW CCCCCCCCHHHHHHH | 17.55 | OGP | |
1107 | Phosphorylation | QDVLGMVTVAGVPCA HHHHCCCEECCCCEE | 8.85 | 26074081 | |
1183 | N-linked_Glycosylation | GGTRLTLNGSKLLTG CCEEEEECCCCCCCC | 47.67 | UniProtKB CARBOHYD | |
1253 | N-linked_Glycosylation | FKYTLDPNITSAGPT CEEECCCCCCCCCCC | 50.24 | 19159218 | |
1330 | N-linked_Glycosylation | FEEPCHVNSSQLITC CCCCCCCCHHHCEEE | 16.57 | 19159218 | |
1524 | Ubiquitination | QALRDYKKVQIQLEN HHHHHHHHHHHHHHC | 32.89 | 29967540 | |
1534 | Phosphorylation | IQLENLESSVRDRCK HHHHCHHHHHHHHHH | 36.98 | 24719451 | |
1535 | Phosphorylation | QLENLESSVRDRCKK HHHCHHHHHHHHHHH | 16.28 | 28857561 | |
1545 | Phosphorylation | DRCKKEFTDLMTEMT HHHHHHHHHHHHHHH | 29.34 | 22210691 | |
1549 | Phosphorylation | KEFTDLMTEMTDLTS HHHHHHHHHHHHHHH | 29.87 | 25954137 | |
1552 | Phosphorylation | TDLMTEMTDLTSDLL HHHHHHHHHHHHHHH | 22.94 | 22210691 | |
1556 | Phosphorylation | TEMTDLTSDLLGSGI HHHHHHHHHHHCCCC | 33.29 | 25954137 | |
1568 | Phosphorylation | SGIPFLDYKVYAERI CCCCCCCEEEEEEEC | 12.42 | 22210691 | |
1583 | Phosphorylation | FFPGHRESPLHRDLG CCCCCCCCCCCCCCC | 32.49 | 23532336 | |
1612 | Phosphorylation | QLSNLLNSKLFLTKF HHHHHHHHHHHHHHH | 30.61 | - | |
1667 | Phosphorylation | LSDLVAQYVAKNPKL HHHHHHHHHHHCCCH | 7.82 | - | |
1708 | Phosphorylation | DSVGEPLYMLFRGIK CCCCCHHHHHHHHHC | 11.50 | 19805522 | |
1727 | Phosphorylation | KGPVDSVTGKAKYTL CCCCCCCCCEEEEEC | 36.60 | 23911959 | |
1732 | Phosphorylation | SVTGKAKYTLNDNRL CCCCEEEEECCCCCC | 22.71 | 19805522 | |
1855 | Ubiquitination | ALVPCLTKHVLRENQ EHHHHHHHHHHHHCC | 20.83 | 29967540 | |
1864 | Phosphorylation | VLRENQDYVPGERTP HHHHCCCCCCCCCCC | 9.97 | 28796482 | |
1870 | Phosphorylation | DYVPGERTPMLEDVD CCCCCCCCCCCCCCC | 14.56 | - | |
1902 | Phosphorylation | PPRPRRGSLRGGERE CCCCCCCCCCCCHHH | 17.06 | 22817900 | |
1928 | Phosphorylation | RLLSMKGTLQKFVDD HHHHCCHHHHHHHHH | 22.09 | - | |
1980 | Phosphorylation | IHIWKTNSLPLRFWI EEEEECCCCCEEEEE | 36.27 | 24719451 | |
2001 | Phosphorylation | QFVFDVQTSDNMDAV CEEEEECCCCCHHHH | 37.59 | 27251275 | |
2002 | Phosphorylation | FVFDVQTSDNMDAVL EEEEECCCCCHHHHH | 15.19 | 27251275 | |
2051 | Methylation | RYKRMVERYYADIRQ HHHHHHHHHHHHHHH | 20.53 | 24383357 | |
2131 | Ubiquitination | IAAAVENKVTDL--- HHHHHHHHCCCC--- | 32.76 | 29967540 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLXB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLXB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RND1_HUMAN | RND1 | physical | 12730235 | |
RND2_HUMAN | RND2 | physical | 12730235 | |
RND3_HUMAN | RND3 | physical | 12730235 | |
ARHGB_HUMAN | ARHGEF11 | physical | 12730235 | |
ARHGB_HUMAN | ARHGEF11 | physical | 12123608 | |
ARHGB_HUMAN | ARHGEF11 | physical | 12220504 | |
ARHGC_HUMAN | ARHGEF12 | physical | 12220504 | |
RHOA_HUMAN | RHOA | physical | 19805522 | |
AKT1_HUMAN | AKT1 | physical | 19805522 | |
GRB2_HUMAN | GRB2 | physical | 19805522 | |
PLCG1_HUMAN | PLCG1 | physical | 19805522 | |
PLCG2_HUMAN | PLCG2 | physical | 19805522 | |
SMPX_HUMAN | SMPX | physical | 28514442 | |
HBB_HUMAN | HBB | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1253, AND MASSSPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1253 AND ASN-1330, ANDMASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-1253, AND MASSSPECTROMETRY. |